The periodical about the pharmaceutical and medical equipment markets
(Russian pharmacies) - specialized periodical edition for pgarmacy professionals
Medical Council - Scientific Journal for Physicians
Russian pharmaceutical company R-Pharm is going ahead with the projected EUR 100 million investment in Turkey. R-Pharm’s investment involves a biotechnology manufacturing plant in Turkey to supply both the domestic and regional markets.
Abbott announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer.
Following the successful acquisition of Kilian Tableting GmbH, the Romaco Group is continuing its expansion into Asia.
The Russian pharmaceutical industry is facing many regulatory challenges and shifts in the use of digital. Because of this it’s important to understand what companies are doing to tackle these challenges, so eyeforpharma have been looking into which areas are most important to you.
1 - 5 of 735
Many global vaccines players count on emerging markets for sales growth, but some of them may not be able to count on Russia for much longer. Multinationals may lose some of their access to the market thanks to pressure from state corporation Rosteh, with 11 billion rubles ($300 million) in state contracts at stake.
First | Prev. |
programmer of electronic software products